9798337352695 - ai, nanobiotechnology, and the future of precision antibiotics (7 risultati)
- Brossura
Da: PBShop.store UK, Fairford, GLOS, Regno UnitoPBShop.store UK
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 186,97
EUR 6,87 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
- Brossura
Da: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 194,39
Spedizione gratuitaSpedito in U.S.A.Quantità: Più di 20 disponibili
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
- Brossura
- Print on Demand
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 232,28
Spedizione gratuitaSpedito in U.S.A.Quantità: 1 disponibili
Paperback. Condizione: new. Paperback. Antimicrobial resistance has become a defining global health emergency, eroding the effectiveness of existing therapies and placing millions of lives at risk as pathogens evolve faster than conventional drug development can respond. The scale and speed of this crisis expose fundamental limi…tations in traditional antibiotic discovery, which remains costly, slow, and poorly aligned with the biological complexity of infections. Advances in artificial intelligence (AI) offer the ability to rapidly explore vast chemical spaces and uncover novel antibacterial strategies, while nanobiotechnology enables precise delivery systems that can uncover biological barriers and reduce toxicity. When combined, these approaches open the door to precision antibiotics. Developing and integrating these technologies is therefore not optional but essential to restoring humanity's ability to control infectious diseases. AI, Nanobiotechnology, and the Future of Precision Antibiotics addresses the escalating global challenge of antimicrobial resistance, which continues to undermine the effectiveness of existing therapies and place growing pressure on healthcare systems worldwide. This volume presents an integrative perspective that brings together computational modeling, nanoscale engineering, and biologically informed therapeutic design within a unified conceptual framework. It highlights the convergence of these domains as a pathway toward more adaptive and effective antimicrobial solutions. Covering key topics such as antimicrobial therapies, nanocarrier technologies, and predictive modeling, this book serves as a valuable resource for researchers, clinicians, engineers, and policy-oriented scholars working across AI, nanomedicine, antimicrobial research, and global health innovation. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
- Brossura
- Print on Demand
Da: CitiRetail, Stevenage, Regno UnitoCitiRetail
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 196,39
EUR 43,28 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Paperback. Condizione: new. Paperback. Antimicrobial resistance has become a defining global health emergency, eroding the effectiveness of existing therapies and placing millions of lives at risk as pathogens evolve faster than conventional drug development can respond. The scale and speed of this crisis expose fundamental limi…tations in traditional antibiotic discovery, which remains costly, slow, and poorly aligned with the biological complexity of infections. Advances in artificial intelligence (AI) offer the ability to rapidly explore vast chemical spaces and uncover novel antibacterial strategies, while nanobiotechnology enables precise delivery systems that can uncover biological barriers and reduce toxicity. When combined, these approaches open the door to precision antibiotics. Developing and integrating these technologies is therefore not optional but essential to restoring humanity's ability to control infectious diseases. AI, Nanobiotechnology, and the Future of Precision Antibiotics addresses the escalating global challenge of antimicrobial resistance, which continues to undermine the effectiveness of existing therapies and place growing pressure on healthcare systems worldwide. This volume presents an integrative perspective that brings together computational modeling, nanoscale engineering, and biologically informed therapeutic design within a unified conceptual framework. It highlights the convergence of these domains as a pathway toward more adaptive and effective antimicrobial solutions. Covering key topics such as antimicrobial therapies, nanocarrier technologies, and predictive modeling, this book serves as a valuable resource for researchers, clinicians, engineers, and policy-oriented scholars working across AI, nanomedicine, antimicrobial research, and global health innovation. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
- Brossura
- Print on Demand
Da: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 255,06
EUR 31,99 spedizioneSpedito da Australia a U.S.A.Quantità: 1 disponibili
Paperback. Condizione: new. Paperback. Antimicrobial resistance has become a defining global health emergency, eroding the effectiveness of existing therapies and placing millions of lives at risk as pathogens evolve faster than conventional drug development can respond. The scale and speed of this crisis expose fundamental limi…tations in traditional antibiotic discovery, which remains costly, slow, and poorly aligned with the biological complexity of infections. Advances in artificial intelligence (AI) offer the ability to rapidly explore vast chemical spaces and uncover novel antibacterial strategies, while nanobiotechnology enables precise delivery systems that can uncover biological barriers and reduce toxicity. When combined, these approaches open the door to precision antibiotics. Developing and integrating these technologies is therefore not optional but essential to restoring humanity's ability to control infectious diseases. AI, Nanobiotechnology, and the Future of Precision Antibiotics addresses the escalating global challenge of antimicrobial resistance, which continues to undermine the effectiveness of existing therapies and place growing pressure on healthcare systems worldwide. This volume presents an integrative perspective that brings together computational modeling, nanoscale engineering, and biologically informed therapeutic design within a unified conceptual framework. It highlights the convergence of these domains as a pathway toward more adaptive and effective antimicrobial solutions. Covering key topics such as antimicrobial therapies, nanocarrier technologies, and predictive modeling, this book serves as a valuable resource for researchers, clinicians, engineers, and policy-oriented scholars working across AI, nanomedicine, antimicrobial research, and global health innovation. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
- Brossura
- Print on Demand
Da: preigu, Osnabrück, Germaniapreigu
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 249,35
EUR 70,00 spedizioneSpedito da Germania a U.S.A.Quantità: 5 disponibili
Taschenbuch. Condizione: Neu. AI, Nanobiotechnology, and the Future of Precision Antibiotics | Reyed M. Reyed | Taschenbuch | Englisch | 2026 | IGI GLOBAL SCIENTIFIC PUBLISHING | EAN 9798337352695 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on…Demand.
- Brossura
- Print on Demand
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 300,56
EUR 64,57 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Antimicrobial resistance has become a defining global health emergency, eroding the effectiveness of existing therapies and placing millions of lives at risk as pathogens evolve faster than conventional drug development can respond. The… scale and speed of this crisis expose fundamental limitations in traditional antibiotic discovery, which remains costly, slow, and poorly aligned with the biological complexity of infections. Advances in artificial intelligence (AI) offer the ability to rapidly explore vast chemical spaces and uncover novel antibacterial strategies, while nanobiotechnology enables precise delivery systems that can uncover biological barriers and reduce toxicity. When combined, these approaches open the door to precision antibiotics. Developing and integrating these technologies is therefore not optional but essential to restoring humanity's ability to control infectious diseases. AI, Nanobiotechnology, and the Future of Precision Antibiotics addresses the escalating global challenge of antimicrobial resistance, which continues to undermine the effectiveness of existing therapies and place growing pressure on healthcare systems worldwide. This volume presents an integrative perspective that brings together computational modeling, nanoscale engineering, and biologically informed therapeutic design within a unified conceptual framework. It highlights the convergence of these domains as a pathway toward more adaptive and effective antimicrobial solutions. Covering key topics such as antimicrobial therapies, nanocarrier technologies, and predictive modeling, this book serves as a valuable resource for researchers, clinicians, engineers, and policy-oriented scholars working across AI, nanomedicine, antimicrobial research, and global health innovation.
